Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
about
Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and ApoptosisAnthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.MicroRNA-210 Plays a Critical Role in the Angiogenic Effect of Isoprenaline on Human Umbilical Vein Endothelial Cells via Regulation of Noncoding RNAsMicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.microRNA and thyroid hormone signaling in cardiac and skeletal muscle.MiR-30c regulates cisplatin-induced apoptosis of renal tubular epithelial cells by targeting Bnip3L and Hspa5.MiR-30e attenuates isoproterenol-induced cardiac fibrosis through suppressing Snai1/TGFβ signaling.Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system.Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.Circadian MicroRNAs in Cardioprotection.Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity.Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy.Response to Letter Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study".MicroRNA as a Therapeutic Target in Cardiac Remodeling.The Positive Effects of Exercise in Chemotherapy-Related Cardiomyopathy.MicroRNA-30c-5p ameliorates hypoxia-reoxygenation-induced tubular epithelial cell injury via HIF1α stabilization by targeting SOCS3.Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy.Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases.Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.A novel system-level approach using RNA-sequencing data identifies miR-30-5p and miR-142a-5p as key regulators of apoptosis in myocardial infarction
P2860
Q26746965-637B90A7-7F84-4FBD-B89A-2D8811682D56Q33658456-D5FF49EC-1306-44D7-B74B-7ACF671860F8Q36188321-413A9793-037A-4EB7-A1D2-2772021D34B4Q37447462-0EA1F824-8AE5-43B6-B52F-B6F4F5F46495Q37641769-F322081B-2E24-4312-8B8E-48EFB6286F04Q37713451-589FD17E-D20C-458F-A61F-0ABB184D25DEQ38630687-B23095B5-0DEF-4AF7-84C8-69EA254DB59CQ38641091-A00DDC0D-3525-42DB-96DC-3C2165F0E411Q38657244-1E6482D4-761C-45DD-8D52-950705B35494Q38830661-549006A8-7BAB-493E-BDCF-6016B0F318EBQ39195350-28F2D9CA-55DE-4AF5-A309-99111C92887CQ39264180-9008AF1D-B460-44F2-8B93-8AD65743B02EQ39403789-316DB1CB-97D5-4EF9-BCF5-E60C27D746E7Q39430271-D2F49D37-AF3B-4026-9592-2D4415F23103Q41072198-CD48011D-F346-4CA3-BBF9-10814F3B3B1FQ41717594-C7A58172-BC05-4677-8858-3EB14A5B22FCQ41983421-DA91F59C-B6AF-4961-8A86-A55B95986739Q42562572-55F19CB3-68AE-46AC-BF85-8BBB4B05E151Q44732086-D85D03BA-4AA1-416E-AEC3-B279D61DF7A3Q46269647-AB288E4F-8904-457D-B7A5-60792A93BC60Q46861963-64D9C5A8-A262-4358-918D-33A1EF180DD4Q47929107-B678D1FD-2A7E-44F7-BF3E-CA1A2C7A667DQ47943382-5B243837-2F6B-48AB-827E-0B2F24BB8C0AQ47947947-FC3E0BF2-1505-4448-AD76-E0887B968EF4Q52642353-2E1374ED-2624-41AA-8D27-FF448E0C3F35Q53095027-88BC9642-6499-438B-8EE8-5678680D819CQ57050279-363A6E6F-DCFC-4126-9A55-6D8660E94E8B
P2860
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
description
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2015
@ast
im Mai 2015 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2015/05/07)
@sk
vědecký článek publikovaný v roce 2015
@cs
wetenschappelijk artikel (gepubliceerd op 2015/05/07)
@nl
наукова стаття, опублікована в травні 2015
@uk
مقالة علمية (نشرت في 7-5-2015)
@ar
name
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@ast
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@en
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@nl
type
label
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@ast
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@en
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@nl
prefLabel
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@ast
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@en
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@nl
P2093
P2860
P50
P3181
P356
P1476
Myocardial MiR-30 downregulati ...... gnaling and enhances apoptosis
@en
P2093
A E Frampton
A F Dabrowska
L Pellegrino
L Roca-Alonso
R C Coombes
P2860
P3181
P356
10.1038/CDDIS.2015.89
P577
2015-05-07T00:00:00Z